P2Y nucleotide receptors in the immune system: Signaling by a P2Y2 receptor in U937 monocytes

Drug Development Research

Volumn 45, Issue 3-4, 1998, Pages 222-228

  Weisman, Gary A ^a  

^a University of Missouri   (United States)

Author keywords

Immune system; Monocytes; P2Y2 receptors; Purinergic receptors; UTP

Indexed keywords

PURINE P2Y RECEPTOR;

CELL LINE; CONFERENCE PAPER; DRUG TARGETING; IMMUNE SYSTEM; MONOCYTE; RECEPTOR INTRINSIC ACTIVITY; SIGNAL TRANSDUCTION;

EID: 0032467618     PISSN: 02724391     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2299(199811/12)45:3/4<222::AID-DDR20>3.0.CO;2-8     Document Type: Conference Paper

References (59)

1. 2 integrin) surface expression on peripheral blood leukocytes. Biochem Biophys Res Commun 233:71-75.
2. Alonso-Torre SR, Trautmann A. 1993. Calcium responses elicited by nucleotides in macrophages: interaction between two receptor subtypes. J Biol Chem 268:18640-18647.
3. Altieri DC, Wiltse WL, Edgington TS. 1990. Signal transduction initiated by extracellular nucleotides regulates the high affinity ligand recognition of the adhesive receptor CDllb/CD18. J Immunol 145:662-670.
4. 2+ by adenine nucleotides in human T-leukaemia cells: evidence for ADP-specific and Psy-purinergic receptors. Biochem J 304:769-774.
5. Boarder MR, Weisman GA, Turner JT, Wilkinson GE1995. G protein-coupled P2 purinoceptors: from molecular biology to functional responses. TIPS 16:133-139.
6. 3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels. Cell 79:1157-1165.
7. 3 for angiogenesis. Science 264:569-571.
8. 7 receptor. J Cell Biol 138:697-706.
9. Clifford EE, Martin KA, Dalai P, Thomas R, Dubyak GR. 1997. Stagespecific expression of P2Y receptors, ecto-apyrase, and ecto-5′-nucleotidase in myeloid leukocytes. Am J Physiol 273:C973-C987.
10. Cowen DS, Lazanis HM, Shurin SB, Stoll SE, Dubyak GR. 1989. Extracellular adenosine triphosphate activates calcium mobilization in human phagocytic leukocytes and neutrophil/monocyte progenitor cells. J Clin Invest 83:1651-1660.
11. Cowen DS, Berger M, Nuttle L, Dubyak GR. 1991. Chronic treatment with P2-purinergic receptor agonists induces phenotypic modulation of the IIL-60 and U937 human myelogenous leukemia cell lines. J Leukoc Biol 50:109-122.
12. Denlinger LC, Fisette PL, Garis KA, Kwon G, Vazquez-Torres A, Simon AD, Nguyen B, Proctor RA, Bertics PJ, Corbett JA. 1996. Regulation of inducible nitric oxide synthase expression by macrophage purinoreceptors and calcium. J Biol Chem 271:337-342.
13. el-Moatassim C, Dubyak GR. 1992. A novel pathway for the activation of phospholipase D by P-22 purinergic receptors in BAC1.2F5 macrophages. J Biol Chem 267:23664-23673.
14. 2z purinergic receptors in BAC1.2F5 macrophages: product inhibition of phospholipase D enzyme activity. J Biol Chem 268:15571-15578.
15. 2 purinoceptor in transformed mouse fibroblasts. J Biol Chem 265:7424-7431.
16. Erb L, Garrad R, Wang Y, Quinn T, Turner JT, Weisman GA. 1995. Site-directed mutagenesis of Pau purinoceptors: positively charged amino acids in Iransmembrane helices 6 and 7 affect agonist potency and specificity. J Biol Chem 270:4185-1188.
17. 2 nucleolide receptor. Drug Dev Res 43:44.
18. Ferrari D, Chiozzi P, Falzoni S, Dal Susino M, Melchiorri L, Baricordi OR, Di Virgilio E 1997. Extracellular ATP triggers IL-lβ release by 'activating the purinergic P2Z receptor of human macrophages. J Immunol 159:1451-1458.
19. FiItzTM, LiQ, Boyer JL, Nicholas RA, Harden TK. 1994. Expression of a cloned P-2\ purinergic receptor that couples to phospholipase C. Mol Pharmacol 46:8-14.
20. Fredholm BB, Abbracchio MR Bumstock G, Daly JW, Harden TK, Jacobson KA, Leff P, Williams M. 1994. Nomenclature and classification of purinoceptors. Pharmacol Rev 46:143-156.
21. Freedman NJ, Lefkowitz RJ. 1996. Desensitization of G protein-coupled receptors. Recent Prog Horm Res 51:319-351.
22. Gargett CE, Wiley JS. 1997. The isoquinoline derivative KN-62 a potent antagonist of the P2Z-receptor of human lymphocytes. Br J Phannacol 120:1483-1490.
23. 2 nucleotide receptor: consequences of truncation of the C-terminus. J Biol Chem 273:29437-29444.
24. Gonzalez FA, Alimed AH, Lustig KD, Erb L, Weisman GA. 1989a. Permeabilization of transformed mouse fibroblasts by 3′-O-(4-benzoyl)benzoyl adenosine 5′-triphosphate and the desensitization of the process. J Cell Physiol 139:109-115.
25. Gonzalez FA, Bonapace E, Beizer I, Friedberg I, Heppel LA. 1989b. Two distinct receptors for ATP can be distinguished in Swiss 3T6 mouse fibroblasts by their desensitization. Biochem Biophys Res Commun 164:706-713.
26. Greenberg SS, Zhao X, Wang JE Hua L, Ouyang J. 1997. cAMP and purinergic P2y receptors upregulate and enhance induciblc NO synthase mRNA and protein in vivo! Am J Physiol 273:L967-L979.
27. Hagenlocker BE, Walker BAM, Ward PA. 1990. Superoxide responses of immune complex-stimulated rat alveolar macrophages: intracellular calcium and priming. J Immunol 144:3898-3906.
28. Harris P, Ralph R 1985. Human leukemic models of myelomonocytic development: a review of the HL-60 and U937 cells. J Leukoc Biol 37:407-422.
29. Hayashi T, Rao S P, Catanzaro A. 1997. Binding of the 68-kilodalton protein of Mycobacterium acium to 0,3 on human monocyte-derived macrophages enhances complement receptor type 3 expression. Infect Immun 65:1211-1216.
30. Hendey B, Lawson M, Marcantonio EE, Maxfield FR. 1996. Intracellular calcium and calcineurin regulate neutrophil motility on vitronectin through a receptor identified by antibodies to integrins Ov and P3. Blood 87:2038-2048.
31. Hughes J, Liu Y, Van Damme J, Savill . 1997. Human glomenilar mesangial cell phagocytosis ofapoptotic neutrophils: mediation by a novel CD36-independent vitronectin receptor/thrombospondin recognition mechanism that is uncoupled from chemokine secretion. J Immunol 158:4389-4397.
32. Ichinose M. 1995. Modulation of phagocytosis by P2-purinergic receptors in mouse peritoneal macrophages. Jpn J Physiol 45:707-721.
33. Jiang Q, Guo D, Lee BX, van Rhee AM, Kirn YC, Nicholas RA, Schachter JB, Harden TK, Jacobson, KA. 1997. A mutational analysis of residues essential for ligand recognition at the human P2Yi receptor. Mol Pharmacol 52:499-507.
34. Koshiba M, Apasov S, Sverdlov P, Chen P, Erb L, Turner JT, Weisman GA, Sitkovsky MV. 1997. Transient up-regulation of P2Y2 nucleotide receptor mRNA expression is an immediate early gene response in activated thymocytes. Proc Nail Acad Sei USA 94:831-836.
35. Kuhns DB, Wright DG, Nath J, Kaplan SS, Basford RE. 1988. ATP induces transient elevations in [Ca2+]j in human neutrophils and primes these cells for enhanced Oo~ generation. Lab Invest 58:448-453.
36. Kuroki M, Takeshige K, Minakami S. 19S9. ATP-induced calcium mobilization in human neutrophils. Biochim Biophys Acta 1012:103-106.
37. Lin WW, Lee YT. 1996. Pyrimidinoceplor-mediated activation of phospholipase C and phospholipase A2 in RAW 264.7 macrophages. Br J Pharmacol 119:261-268.
38. Lindberg FP, Gresham HD, Reinhold MI, Brown EJ. 1996. Integrin-associated protein immunoglobulin domain is necessary for efficient vitronectin bead binding. J Cell Biol 134:1313-1322.
39. Lustig KD, Shiau AK, Brake AJ, Julius D. 1993. Expression cloning of an ATP receptor from mouse neuroblastoma cells. Proc Nail Acad Sei USA 90:5113-5117.
40. 2upurinergic nucleotide receptor messenger RNA expression during in vitro differentiation of human myeloid leukocytes by phorbol esters or inflammatory activators. Mol Pharmacol 51:97-108.
41. Müller G, KerkhoffC, Hankowitz J, Palaki M, Kovacs E, Lackner KJ, Schmilz G. 1993. Effects of purinergic agents on human mononuclear phagocytes are differentiation dependent: implications for atherogenesis. Arterioscler Thromb 13:1317-1326.
42. Murgia M, Hanau S, Pizzo P, Rippa M, Di Virgilio E 1993. Oxidized ATP: an irreversible inhibitor of the macrophage purinergic P2z receptor. J Biol Chem 268:8199-8203.
43. Murphy JK, Livingston FR, Gozal E.Torres M, Forman HJ. 1993. Stimulation of the rat alveolar macrophage respirator)' burst by extracellular adenine nucleotides. Am J Respir Cell Mol Biol 9:505-510.
44. Naumov AP, Kaznacheyeva EV, Kuryshev YA, Mozhayeva GN. 1995. Selectivity of ATP-activated GTP-dependent Ca -permeable channels in rat macrophage plasma membrane. J Membr Biol 148:91-93.
45. Padeh S, Cohen A, Roifman CM. 1991. ATP-induced activation of human B lymphocytes via P2-purinoceptors. J Immunol 146:1626-1632.
46. Parr CE, Sullivan DM, Paradiso AM, Lazarowsla ER, Durch LH, Olsen JC, Erb L, Weisman GA, Boucher RC, Turner JT. 1994. Cloning and expression of a human Pju nucleotide receptor, a target for cystic fibrosis pharmacotherapy. Proc Natl Acad Sei USA 91:3275-3279.
47. Pierschbacher MD, Rouslahti C. 1984. Cell attachment activity of fibronectin can be duplicated by small fragments of the molecule. Nature 309:30-33.
48. 2-adrenergic receptors permit receptor resensitization. Mol Pharmacol 47:666-676.
49. Steinberg TH, Newman AS, Swanson JA, Silverstein SC. 19S7. ATP4 permeabilizes the plasma membrane of mouse macrophages to fluorescent dyes. J Biol Chem 262:8884-8888.
50. 2 nucleotide receptors in rat salivary gland cells during short-term culture. Am J Physiol 273:C1100-C1107.
51. Turner JT, Weisman GA, Fedan JS. 1998. The P2 nucleotide receptors. Totowa, NJ: Humana Press. van Rhee AM, Jacobson KA, Garrad R, Weisman GA, Erb L. 1998. P2 receptor modeling and identification of ligand binding sites. In: Turner JT, Weisman GA, Fedan JS, editors. The P2 nucleotide receptors. Totowa, NJ: Humana Press, p 135-166.
52. Ventura MA, Thomopoiilos E 1995. ADP and ATP activate distinct signaling pathways in human promonocytic U-937 cells differentiated with 1,25-dihy.droxy-vitamin D3. Mol Pharmacol 47:104-114.
53. Vennes I, Haanen C. 1994. Apoptosis and programmed cell death in health and disease. Adv Clin Chem 31:177-246.
54. Webb TE, Simon J, Krishek BJ, Bateson AN, Smart TG, King BF, Bumstock G, Barnard EA. 1993. Cloning and functional expression of a brain G-protein-coupled ATP receptor. FEES Lett 324:219-225.
55. Weisman GA, De BK, Friedberg I, Pritchard RS, Heppel LA. 1984. Cellular responses to external ATP which precede an increase in nucleotide permeability in transformed cells. J Cell Physiol 119:211-219.
56. Weisman GA, Turner JT, Clarke LL, Gonzalez FA, Otero M, Garrad RC, Erb L. 1997. P2 nucleotide receptor structure and function. In: Plesner L, Kirley TL, Knowles AF, editors. Ecto-ATPases. New York: Plenum Press, p 231-237.
57. Weisman GA, Gonzalez FA, Erb'L, Garrad RC, Turner JT. 1998. The cloning and expression of üprotein-coupled P2Y nucleotide receptors. In: Turner JT, Weisman GA, Fedan JS, editors. The P2 nucleotide receptors. Totowa, NJ: Humana Press, p 63-79.
58. 2Y purinoceptors and nucleotide receptors) coexisting on endothelial cells. Mol Pharmacol 45:731-736.
59. Yu SS, Lefkowitz RJ, Hausdorff WE 1993. -Adrenergic receptor sequestration: a potential mechanism of receptor resensitization. J Biol Chem 268:337-341.